Camrelizumab combined with FLOFOX as neoadjuvant therapy for resectable locally advanced gastric and gastroesophageal junction adenocarcinoma: Updated results of efficacy and safety.Ying Liu, Danyang Li, Jing Zhuang et al.|Journal of Clinical Oncology|2021Cited by 36
First-line gemcitabine and oxaliplatin (GEMOX) plus sorafenib, followed by sorafenib as maintenance therapy, for patients with advanced hepatocellular carcinoma: a preliminary studyYing Liu, Jufeng Wang, Feng Wang et al.|International Journal of Clinical Oncology|2015Cited by 31
PPM1D Functions as Oncogene and is Associated with Poor Prognosis in Esophageal Squamous Cell CarcinomaKe Li, Jufeng Wang, Ying Liu et al.|Pathology & Oncology Research|2018Cited by 27